POLY MEDICURE
|
|
| BOM : 531768 NSE : POLYMED | |
| LT :
Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : Average |
Updated: |
| ST :
Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward Pledged Shares : None or < 25% |
May 20,2022 |
|
Price(EOD): ₹ 728.30
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Medical Equipment/Supplies/Accessories |
| MCap: ₹ 6,984.40 Cr | |
FUNDAMENTAL ANALYSIS OF POLY MEDICURE
[ Q(TTM): Dec2021, Y: Mar2021
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF POLY MEDICURE
[As on : May 20,2022
]
| Ratio | Consolidated | |
|---|---|---|
|
P/E P/B P/S |
51.4
P/E Calculated based on EPS of 14.17
[ Mar2021 - Consolidated Results ] 7.24
P/B Calculated based on Book Value of 100.62
[ Mar2021 - Consolidated Results ] 7.95
P/S Calculated based on Revenues of 878.542 Cr
[ TTM - Consolidated Results ] |
|
| Financial Ratios → | ||
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
186% 264% 274% |
SHARE PRICE MOMENTUM OF POLY MEDICURE
POLY MEDICURE vs SENSEX
DEBT OF POLY MEDICURE
| Year | Debt/Equity ratio | |
|---|---|---|
| Standalone | Consolidated | |
|
2021 2020 2019 Avg_3yrs |
0.13 0.44 0.4 0.32 |
0.14 0.47 0.42 0.34 |
|
[Last Annual Data : Mar2021]
|
||
| Financial Ratios → | ||
PLEDGED PROMOTER SHARES OF POLY MEDICURE
| Pledged Promoter Shares |
0 % | |
|---|---|---|
| As on : Mar2022 | ||
If less than 25% | Good |
|
| If between 25% and 50% | Neutral | |
| If greater than 50% | Bad | |
| Shareholding Pattern → | ||
QTRLY RESULTS OF POLY MEDICURE
| Consolidated | Q-o-Q | Y-o-Y |
|---|---|---|
|
Revenue Op Profit Profit Before Tax Profit After Tax |
3.09% 0.64% -8.34% -8.77% |
13.15% -11.45% -0.44% -2.34% |
| QtrlyTrend |
-2 | |
| Latest Qtr: Dec2021 | ||
| Quarterly Result Analysis → | ||
POLY MEDICURE related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE 250 SMALLCAP | 4.5% | -9.8% | 12.8% |
| S&P BSE SMALL CAP | 4.1% | -8.7% | 16.8% |
| S&P BSE MIDSMALLCAP | 3.7% | -8.4% | 12.6% |
| S&P BSE 400 MIDSMALLCAP | 3.6% | -7.9% | 11.9% |
| S&P BSE ALLCAP | 3.2% | -5.8% | 10.3% |
| S&P BSE 500 | 3.2% | -5.6% | 9.7% |
| S&P BSE HEALTHCARE | 2.8% | -6.4% | -4.8% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY SMALLCAP250 | 4.5% | -10% | 13.6% |
| NIFTY MID SMALL400 | 3.4% | -8% | 12.5% |
| NIFTY500 MULTICAP 50:25:25 | 3.4% | -6.8% | 11% |
| NIFTY 500 | 3.1% | -5.7% | 9.7% |
You may also like the below Video Courses
FAQ about POLY MEDICURE
Is POLY MEDICURE good for long term investment?
As on May 20,2022, the Fundamentals of POLY MEDICURE look Strong and hence it may be good for long term investment! See Financial Performance of POLY MEDICURE . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is POLY MEDICURE UnderValued or OverValued?
As on May 20,2022, POLY MEDICURE is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of POLY MEDICURE ?
As on May 20,2022, the Intrinsic Value of POLY MEDICURE is Rs. 199.99 determined based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 254.77
Fair Value [Median EV / Sales Model] : Rs. 199.99
Fair Value [Median Price / Sales Model] : Rs. 194.52
Median Fair Value of POLY MEDICURE : Rs. 199.99
Is POLY MEDICURE trading at a Premium or Discount?
As on May 20,2022, POLY MEDICURE is trading at a Premium of 264% based on the estimates of Median Intrinsic Value!
Check out Annual Financials of Industry Peers
|
Financials of OPTO CIRCUITS (INDIA) LTD | BOM: 532391 | NSE: OPTOCIRCUI |
Check out Quarterly Results of Industry Peers
|
Quarterly Results of OPTO CIRCUITS (INDIA) LTD |
Browse Market Cap of Industry Peers
|
Market Cap of OPTO CIRCUITS (INDIA) LTD |
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].
